Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Rhythm Pharmaceuticals, Inc.
Age
2–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Males and females ≥2 years of age who have completed a previous setmelanotide clinical study and who have a condition or indication for which Rhythm plans further clinical development.
Agree to use a highly effective form of contraception and follow the study contraception requirements throughout study duration and for 90 days after.
Demonstrated clinical benefit in the previous setmelanotide study, as determined by the Investigator.
You may not be if
Any gene variant, syndromic, or acquired disease for which setmelanotide is currently approved in the United States (i.e., patients eligible for commercial setmelanotide (IMCIVREE®).
Any new or worsening depression resulting in suicidal thoughts and/or behaviors.
Discontinuation from a previous setmelanotide study.
History or close family history (parents or siblings) of melanoma.
